Personalized Medicine Market Trends 2025 to 2033 The global personalized medicine market was at US$ 546.97 billion in 2024 and will reach up to US$ 1,009.82 billion by 2033. According to the research work done by Renub Research, the personalized medicine industry is to grow at a CAGR of 7.05% during the time period of 2025-2033. Its growth is furthered because of advancements in genomics, biotechnology, as well as a growing requirement for tailored treatments that enhance therapeutic efficacy and reduce side effects. Read More: https://www.renub.com/saudi-arabia-contact-lenses-market-p.php The report Personalized Medicine Market & Forecast covers by Product (Personalized Medicine Therapeutics, Personalized Medicine Diagnostics, Personalized Medical Care, and Personalized Nutrition and Wellness), Application (Oncology, Infectious disease, Neurology or Psychiatry, Cardiovascular, and Others), End-Users (Hospitals, Diagnostic Centers, Research & Academic Institutes, and Others), Region and Company Analysis 2025-2033. #Personalized_Medicine_Market #Personalized_Medicine_Market_Trends

mRNA Sequencing Market Size and Growth by 2030 The mRNA sequencing market has grown massively within the past few years owing to developments in genomic technologies and applications in a wide range of industries, from personalized medicine and drug development to infection research. mRNA sequencing helps researchers investigate patterns of gene expression that are important in understanding biological processes and the etiology of diseases. https://www.theinsightpartners.com/assets/rd-new-images/by_segmentation/mrna-sequencing-market-strategic-framework.jpg Market Drivers Growth in Genomic Research: Most of the studies on genomics and transcriptomics are growing day by day. The demand for mRNA sequencing also grows. mRNA sequencing has been increasingly used in studies that deal with the expression pattern of an organism. Technological Advance: Advancement in the sequencing platform, including those for NGS, has achieved better speed, accuracy, and economies of scale for mRNA sequencing and greater accessibility to researchers and clinicians. Growing demand for personalized medicine: Increasing demand for personal medicine requires mRNA sequencing with respect to new avenues of therapeutic intervention on the basis of genetic make-up.